A selective inhibitor of thromboxane biosynthesis enhances immediate and inhibits late cutaneous allergic reactions in man
Open Access
- 1 August 1983
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 72 (2), 168-174
- https://doi.org/10.1016/0091-6749(83)90525-0
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Prostaglandin-generating factor of anaphylaxis. Identification and isolation.Journal of Biological Chemistry, 1981
- Allergen tachyphylaxis of guinea pigs in vivo: A prostaglandin E mediated phenomenon?Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1981
- Beneficial effects of a new thromboxane synthetase inhibitor in arachidonate-induced sudden deathThrombosis Research, 1981
- UK-37,248, A novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activityThrombosis Research, 1981
- THROMBOXANE SYNTHETASE INHIBITION AS ANTITHROMBOTIC STRATEGYThe Lancet, 1981
- ADMINISTRATION TO MAN OF UK-37,248-01, A SELECTIVE INHIBITOR OF THROMBOXANE SYNTHETASEThe Lancet, 1981
- Induction of late cutaneous reactions by skin-blister fluid from allergen-tested and normal skinJournal of Allergy and Clinical Immunology, 1981
- Relative refractory state for late cutaneous allergic responsesJournal of Allergy and Clinical Immunology, 1977
- Thromboxane A2: Effects of airway and vascular smooth muscleProstaglandins, 1977
- The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies.JCI Insight, 1976